Evidence map›Paper›PMID 25101890›Full record

ArticlePLoS neglected tropical diseases2014

Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.

Alexander J Lankowski, Alexander C Tsai, Michael Kanyesigye, Mwebesa Bwana, Jessica E Haberer, Megan Wenger, Jeffrey N Martin, David R Bangsberg, Peter W Hunt, Mark J Siedner

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Alexander J LankowskiDepartment of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Alexander C TsaiCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Chester M. Pierce MD Division of Global Psychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Michael KanyesigyeMbarara University of Science and Technology, Mbarara, Uganda.
Mwebesa BwanaMbarara University of Science and Technology, Mbarara, Uganda.
Jessica E HabererCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Megan WengerUniversity of California, San Francisco, San Francisco, California, United States of America.
Jeffrey N MartinUniversity of California, San Francisco, San Francisco, California, United States of America.
David R BangsbergCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Mbarara University of Science and Technology, Mbarara, Uganda; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Boston, Massachusetts, United States of America.
Peter W HuntUniversity of California, San Francisco, San Francisco, California, United States of America.
Mark J SiednerCenter for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Massachusetts General Hospital · USUniversity of California, San Francisco · USCenter for Global Health · USMbarara University of Science and Technology · UG

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGGREY SEMWENDERO SEMEERE, Kara Kay Wools-Kaloustian · 2006 to 2026
$57.7M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Microenterprise to empower and improve health of HIV+ women in UgandaK23MH096620 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TSAI, ALEXANDER C · 2012 to 2016
$922k
Behavioral Aspects of Low-cost Medical Devices to Improve HIV CareK23MH099916 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2013 to 2017
$917k
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaK23MH087228 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2009 to 2013
$916k
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
FIC NIH HHS R24 TW007988FIC NIH HHS R24TW007988NIAID NIH HHS NIH U01 AI069911NIAID NIH HHS P30 AI027763NIAID NIH HHS U01 AI069911NIMH NIH HHS K23 MH087228NIMH NIH HHS K23MH087228NIMH NIH HHS K23 MH096620NIMH NIH HHS K23 MH099916NIMH NIH HHS K23MH099916NIMH NIH HHS K24 MH087227NIMH NIH HHS NIH K23MH096620NIMH NIH HHS NIH K24MH087227NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundThere is conflicting evidence on the immunologic benefit of treating helminth co-infections ("deworming") in HIV-infected individuals. Several studies have documented reduced viral load and increased CD4 count in antiretroviral therapy (ART) naïve individuals after deworming. However, there are a lack of data on the effect of deworming therapy on CD4 count recovery among HIV-infected persons taking ART. METHODOLOGY/PRINCIPAL

findingsTo estimate the association between empiric deworming therapy and CD4 count after ART initiation, we performed a retrospective observational study among HIV-infected adults on ART at a publicly operated HIV clinic in southwestern Uganda. Subjects were assigned as having received deworming if prescribed an anti-helminthic agent between 7 and 90 days before a CD4 test. To estimate the association between deworming and CD4 count, we fit multivariable regression models and analyzed predictors of CD4 count, using a time-by-interaction term with receipt or non-receipt of deworming. From 1998 to 2009, 5,379 subjects on ART attended 21,933 clinic visits at which a CD4 count was measured. Subjects received deworming prior to 668 (3%) visits. Overall, deworming was not associated with a significant difference in CD4 count in either the first year on ART (β = 42.8; 95% CI, -2.1 to 87.7) or after the first year of ART (β =  -9.9; 95% CI, -24.1 to 4.4). However, in a sub-analysis by gender, during the first year of ART deworming was associated with a significantly greater rise in CD4 count (β = 63.0; 95% CI, 6.0 to 120.1) in females. CONCLUSIONS/SIGNIFICANCE: Empiric deworming of HIV-infected individuals on ART conferred no significant generalized benefit on subsequent CD4 count recovery. A significant association was observed exclusively in females and during the initial year on ART. Our findings are consistent with recent studies that failed to demonstrate an immunologic advantage to empirically deworming ART-naïve individuals, but suggest that certain sub-populations may benefit.

Indexed as

CD4 Lymphocyte CountAdultAnti-HIV AgentsCoinfectionFemaleHelminthiasisHIV InfectionsHumansMaleRetrospective StudiesSoilUgandaAnti-HIV AgentsSoil

Identifiers

PMID25101890
PMCPMC4125278
OpenAlexW2103667461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.